Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Deferred Taxes (2016 - 2018)

Cryo Cell International (CCEL) has disclosed Deferred Taxes for 5 consecutive years, with -$738772.0 as the latest value for Q4 2018.

  • On a quarterly basis, Deferred Taxes rose 12.91% to -$738772.0 in Q4 2018 year-over-year; TTM through Nov 2018 was $2.4 million, a 202.34% increase, with the full-year FY2025 number at -$2.8 million, down 811.39% from a year prior.
  • Deferred Taxes was -$738772.0 for Q4 2018 at Cryo Cell International, down from $93826.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $3.0 million in Q1 2018 to a low of -$1.1 million in Q4 2016.
  • A 4-year average of $6797.9 and a median of -$218287.0 in 2015 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: tumbled 159.24% in 2016, then skyrocketed 1296.84% in 2018.
  • Cryo Cell International's Deferred Taxes stood at -$412679.0 in 2015, then crashed by 159.24% to -$1.1 million in 2016, then rose by 20.71% to -$848318.0 in 2017, then rose by 12.91% to -$738772.0 in 2018.
  • Per Business Quant, the three most recent readings for CCEL's Deferred Taxes are -$738772.0 (Q4 2018), $93826.0 (Q3 2018), and -$23895.0 (Q2 2018).